Related Experiment Video
Updated: Jun 27, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
APOBEC proteins and intrinsic resistance to HIV-1 infection
1Department of Infectious Diseases, King's College London School of Medicine, 2nd Floor, Borough Wing, Guy's Hospital, London Bridge, London SE1 9RT, UK. michael.malim@kcl.ac.uk
Insights
APOBEC3G/F proteins inhibit HIV-1 replication by deaminating viral DNA. The viral protein Vif counteracts APOBEC3G/F, and restoring APOBEC3G/F activity is a potential therapeutic strategy.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- APOBEC3G and APOBEC3F are cellular enzymes that inhibit HIV-1.
- The viral protein Vif is essential for HIV-1 infection as it antagonizes APOBEC3G/F.
- Without Vif, APOBEC3G/F cause lethal hypermutation of the viral genome.
Purpose of the Study:
- To investigate the opposing roles of Vif and APOBEC3G/F in HIV-1 infection.
- To explore the therapeutic potential of reactivating APOBEC3G/F in HIV-1-infected cells.
Main Methods:
- Analysis of APOBEC3G/F and Vif interactions within HIV-1 infected cells.
- Assessment of viral genetic integrity and DNA synthesis in the presence and absence of Vif.
- Evaluation of APOBEC3G/F-mediated inhibition of viral DNA replication.
Main Results:
- APOBEC3G/F induce C-to-U editing in viral DNA, leading to G-to-A hypermutations.
- APOBEC3G/F also inhibit viral DNA synthesis by hindering reverse transcriptase translocation.
- The balance between Vif and APOBEC3G/F influences HIV-1 evolution and pathogenesis.
Conclusions:
- The Vif-APOBEC3G/F antagonism is critical for HIV-1 replication and evolution.
- Therapeutic strategies targeting Vif to restore APOBEC3G/F antiviral activity are promising.
Abstract:
Members of the APOBEC family of cellular polynucleotide cytidine deaminases, most notably APOBEC3G and APOBEC3F, are potent inhibitors of HIV-1 infection. Wild type HIV-1 infections are largely spared from APOBEC3G/F function through the action of the essential viral protein, Vif. In the absence of Vif, APOBEC3G/F are encapsidated by budding virus particles leading to excessive cytidine (C) to uridine (U) editing of negative sense reverse transcripts in newly infected cells. This registers as guanosine (G) to adenosine (A) hypermutations in plus-stranded cDNA. In addition to this profoundly debilitating effect on genetic integrity, APOBEC3G/F also appear to inhibit viral DNA synthesis by impeding the translocation of reverse transcriptase along template RNA. Because the functions of Vif and APOBEC3G/F proteins oppose each other, it is likely that fluctuations in the Vif-APOBEC balance may influence the natural history of HIV-1 infection, as well as viral sequence diversification and evolution. Given Vif's critical role in suppressing APOBEC3G/F function, it can be argued that pharmacologic strategies aimed at restoring the activity of these intrinsic anti-viral factors in the context of infected cells in vivo have clear therapeutic merit, and therefore deserve aggressive pursuit.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Retrovirus Life Cycles
Retroviruses
The Intrinsic Apoptotic Pathway

